International Society of Hypertension

ISH - Hero Image 1ISH - Hero Image 2ISH - Hero Image 3ISH - Hero Image 6ISH - Hero Image 8ISH - Hero Image 9ISH - Hero Image 11ISH - Hero Image 12ISH - Hero Image 13ISH - Hero Image 14ISH - Hero Image 15ISH - Hero Image 16ISH - Hero Image 17ISH - Hero Image 18ISH - Hero Image 19ISH - Hero Image 20ISH - Hero Image 21ISH - Hero Image 22ISH - Hero Image 23

Our Officers & Committees

The society is comprised of a range of committees. These are charged with various responsibilities, but ultimately with the same aim of ensuring that it continues to grow and strengthen as the world's premiere blood pressure society, whilst ensuring that youth and developing countries are reflected where possible.

Professor Neil Poulter (International Centre for Circulatory Health (ICCH), London, UK) commenced his ISH presidency on 28th September during the Hypertension Seoul Meeting (26th Scientific Meeting of the International Society of Hypertension).

Scientific Council

The Council is responsible for furthering the aspirations and activities of the ISH, ensuring its efficient running and controlling its property and funds. ISH Scientific Council members are also Trustees of the Charity.

The Executive of the Council (Executive Committee) takes a critical role in helping the Council set policies and goals for the Society, and is delegated to act for the Council in the day-to-day activities of the Society, such as providing direction to the ISH Secretariat, of making the necessary arrangements for the next ISH Biennial Scientific and General Meetings and other scientific activities, of overseeing the work of all committees and working parties, and for giving final consideration for all nominations for membership.

Executive of Council

  • Neil Poulter/Members

    Neil Poulter President

    UK

    more

    My main areas of interest in relation to blood pressure are investigating evaluating the optimisation of blood pressure measurement and control and to ensure maximal prevention of cardiovascular diseases in hypertensive patients from all the major ethnic groups.

  • Alta Schutte / New Investigators Liaison Officer

    Alta Schutte Vice President and Chair, Membership Committee

    South Africa

    more

    As the Research Chair in Chronic Diseases in South Africa, my research spans clinical and epidemiological population studies focusing on the development of hypertension in African communities. By using longitudinal transdisciplinary research programmes I aim to identify novel markers and/or bio-signatures as early predictors of vascular dysfunction in an attempt to contribute to the prevention of hypertension.

  • Maciej Tomaszewski - Scientific Council

    Maciej Tomaszewski Secretary

    UK

    more

    My research interests focus primarily on genetics and genomics of cardiovascular disorders with a particular emphasis on essential hypertension and its complications. I am also interested in genetic and environmental background of sexual dimorphism in cardiovascular risk (why men develop and die of cardiovascular disorders more frequently than age-matched women).

  • Masatsugu Horiuchi

    Masatsugu Horiuchi Treasurer

    Japan

    more

    I am carrying out basic and pharmacological research in hypertension as a research-clinician-scientist. My main research interests include the roles of renin-angiotensin system in blood pressure regulation, vascular biology and brain function with particular regard to cognitive function.

  • Michael Weber/Chair

    Michael Weber Officer at Large and Chair Corporate Liaison Committee

    U.S.A.

    more

    I am involved in the contemporary practice of preventative cardiology, with a focus on hypertension. I am currently the editor of the Journal of Clinical Hypertension and so have an excellent opportunity to be aware of new developments and controversies in the field.

    I have a major interest in clinical trials in patients with hypertension or at high cardiovascular risk, and am particularly interested in how current evidence based on this research -- much of which is inconclusive -- can be used to help define hypertension and guide clinical practice.

    I have also been involved in the development of new drugs for treating hypertension and in understanding how they can be used to the greatest clinical advantage in our patients.

  • Rhian Touyz/Secretary & Forum Officer

    Rhian Touyz Immediate Past President

    UK

    more

    I am the British Heart Foundation Chair in Cardiovascular Medicine, based in the Institute of Cardiovascular and Medical Sciences at the University of Glasgow.

    I am a clinician-scientist investigating the molecular and cellular mechanisms of hypertension. I am committed to hypertension through clinical and basic research, clinical service, teaching, mentoring and leadership and to establishing international networks for trainees and new investigators in hypertension research.

  • Rafael Castillo/Members

    Rafael Castillo Chair, Communications Committee

    Philippines

    more

    As a senior clinical cardiologist at the Manila Doctor’s Hospital and a pioneering faculty member at the Adventist University College of Medicine, I’m part of a group involved in clinical trials evaluating drug and non-drug interventions in the management of high-risk hypertensive patients with various comorbidities. I’m a past president of the Asian Pacific Society of Hypertension, Philippine Heart Association/Philippine College of Cardiology, Philippine Society of Hypertension; and past chair of the Philippine Specialty Board of Adult Cardiology.

  • Fadi Charchar/Members

    Fadi Charchar Chair, Mentorship Scheme Committee and NIC Liaison Officer

    Australia

    more

    My research interests focus on genomics of cardiovascular disease in humans and animal models. I have a special interest in the contribution of the Y chromosome and microRNA to hypertension.

  • Ruan Kruger/Members

    Ruan Kruger Chair, New Investigator Committee

    South Africa

    more

    I am a basic scientist with special interest in clinical and epidemiological population studies focusing on ethnic phenotyping of cardiovascular pathophysiology related to hypertension, arterial stiffness and cardiac impairment (echocardiography). My research particularly includes novel biomarkers and early predictors of cardiovascular disease aiming to contribute to the prevention of early incidence in sub-Saharan Africa.

  • Dorairaj Prabhakaran/Ex-Officio ñ International Development

    Dorairaj Prabhakaran Lead, Global Education Programme

    India

    more

    I am a cardiologist and epidemiologist and currently the Executive Director of Initiative for Cardiovascular Health in Developing Countries (ICHEALTH) and Director Centre of Excellence, Centre for Cardio-metabolic Risk Reduction in South Asia (strategic grant funded by the National Institutes of Health and United Health group) at the Public Health Foundation of India.

  • Ji-Guang Wang/Members

    Ji-Guang Wang Beijing 2018 Meeting Liaison Officer

    China

    more

    My research interests in the field of human hypertension include population-based epidemiological studies, randomized clinical trials, structure and function of the vascular system, and pathophysiological studies on the basis of biological markers such as genetic polymorphisms.

Ordinary Members of the Scientific Council

  • Claudio Borghi

    Claudio Borghi Member

    Italy

    more

    My main areas of interest are the hypertension and related cardiovascular risk factors and drug therapy of hypertensive disease. In particular I am very interested in the interactions between hypertensive disease and metabolic risk factors paying a special attention to epidemiology, pathophysiology and drug treatment including the options supporting the use of different preventive approaches in patients with complex CV risk profile. I am also involved in the development of a nutraceutical approach to the management of hypertension and related risk factors.

  • Hermann Haller - Scientific Council

    Hermann Haller Member

    Germany

    more

    Main interests in clinical research:

    • diagnostics and treatment of renovascular hypertension
    • hypertension and the vasculature in diabetes
    • hypertension in organ transplantation
    • novel therapeutic devices such as carotid sinus stimulation and renal sympathetic nerve ablation Main interests in basic science
    • the biology of the vascular wall and endothelial function
    • endothelial cell permeability
    • cell adhesion and inflammation
    • stem cell precursors of the endothelium
  • Sadayoshi Ito

    Sadayoshi Ito Member

    Japan

    more

    My areas of research are the renin-angiotensin-aldosterone system and glomerular hemodynamics in basic research, and hemodynamics in hypertension, secondary hypertension and chronic kidney disease in clinical research.

  • Nadia Khan

    Nadia Khan Member

    Canada

    more

    I am a clinician scientist in epidemiology and health services research. My research area is focused on ethnic and sex differences in hypertension and cardiovascular disease chronic disease management.

  • Yoshihiro Kokubo - Scientific Council

    Yoshihiro Kokubo Member

    Japan

    more

    I am a chief doctor in the National Cerebral and Cardiovascular Center, Japan. My specialty is preventive medicine and epidemiology, especially related to hypertension and kidney dysfunction. I contribute to many international societies in variety of capacities and editorial board activities in the areas of hypertension, stroke, and preventive medicine.

  • Agustin Ramirez /Member

    Agustin Ramirez Member

    Argentina

    more

    Areas related to hypertension: Renal Sodium Handling, Autonomic Nervous System and Blood Pressure Control, metabolic Syndrome and Hypertension.

  • Markus Schlaich - Scientific Council

    Markus Schlaich Member

    Australia

    more

    I am the Dobney Chair in Clinical Research at the University of Western Australia, based at the Royal Perth Hospital. As a clinician-scientist and renal physician I have specific interest in hypertension associated with chronic kidney disease and the role of the sympathetic nervous system in this scenario. My major aim is to translate evidence from mechanistic studies into clinical practice to improve outcomes for patients with hypertension and associated co-morbidities.

  • Roland Schmieder - Scientific Council

    Roland Schmieder Member

    Germany

    more

    I have extensive experience in the execution of clinical observational and international multicenter studies.

    My research interests include nephrology, hypertension, non-invasive cardiology and vascular medicine, with a focus on hypertensive damage to the heart, kidneys, arteries and retinal circulation and its treatment.

  • Thomas Unger

    Thomas Unger Member

    Netherlands

    more

    My research interest has been focused on peptidergig systems, in particular the Renin-Angiotensin system (RAS) and its CNS-related and peripheral role in the pathophysiology of cardiovascular diseases. As a basic and clinical pharmacologist, I have performed numerous pre-clinical studies and participated in clinical trials investigating the therapeutic aspects of modulating the RAS in hypertension and related diseases, and I have contributed to the development of several RAS modulating drugs.

  • Richard Wainford - Scientific Council

    Richard Wainford Member

    USA

    more

    My research interests are focused on understanding the pathophysiology of hypertension, with particular regard to central neural control of the kidney and the implications of this for long-term blood pressure regulation. As such my research is focused on the areas of: Renal Sodium Handling, Neural Control of Blood Pressure, Salt-Sensitive Hypertension.

Ex-Officio Members of the Scientific Council

  • Louise Burrell/Chair, ISH International Forum

    Louise Burrell Chair, ISH International Forum

    Australia

    more

    My research interests include the pathophysiology of hypertension, with particular regard to the renin angiotensin system; diabetic heart disease and the role of echocardiography; and novel biomarkers in coronary artery disease.

  • Daniel Lackland/WHL Representative

    Daniel Lackland WHL Representative

    USA

    more

    I am the Director of Translational Neuroscience and Population Studies with a focus on implementation science and precision medicine. I continue to serve on clinical practice guidelines panels with research interest involving the population risk assessment of cardiovascular disease, stroke and hypertension. As current President of the World Hypertension League, I have directed effort and focus to the global implementation of prevention and control strategies for high risk populations throughout the world.

  • Lewis Landsberg/Board of Management

    Lewis Landsberg Board of Management

    USA

    more

    Areas of interest in relation to blood pressure:

    • Sympathetic nervous system
    • Obesity-related hypertension
    • The metabolic syndrome
  • Lars H. Lindholm/Hypertension News

    Lars H. Lindholm Hypertension News

    Sweden

    more

    I have been President of the Swedish Society of Hypertension (1989-92), Secretary (the first) of the European Society of Hypertension, ESH (1989-97) , and President of the ISH (2006-8). Since 2009, I have been an honorary member of the British Society of Hypertension.

    My interest in hypertension and its risks started in the late 1970s and I defended my doctoral thesis on this topic in 1994. Since 1998, I am Professor and chairman at the Department of Public Health and Clinical Medicine at Umeå University, Sweden.

  • Trefor Morgan/APSH Representative

    Trefor Morgan APSH Representative

    Australia

    more

    I am a Physiologist Clinician with experimental, and clinical involvement in Salt and water Metabolism and the renin angiotensin system. Trained as a nephrologist and cardiologist.

    Secretary General of the Asian Pacific Society of Hypertension.

  • Josep Redon/ESH Representative

    Josep Redon ESH Representative

    Spain

    more

    Current President of the European Society of Hypertension. Physician, Full Professor of Internal Medicine and Researcher in the field of cardiovascular risk, specialising in the study of mechanisms and development of hypertension-induced organ damage. The most relevant aspects of our research are the following:

    • The search for early markers of organic damage in essential hypertension
    • Introduction and validation of ambulatory measurement techniques during 24-hours of blood pressure
    • Epidemiological Studies
  • Alberto Zanchetti/Board of Management

    Alberto Zanchetti Board of Management

    Italy

    more

    I am Emeritus Professor of Medicine, University of Milan and Scientific Director, Istituto Auxologico Italiano, Milan, Past-President of ISH, and current Editor-in-Chief of the Journal of Hypertension.

    My major scientific interests are neural control of the circulation and the kidney, and antihypertensive treatment.

Awards Committee

The Society offers a number of awards and prizes at each Biennial Scientific Meeting to support basic, clinical and scientific research work into the causes, treatment and prevention of hypertension and associated cardiovascular diseases. A list of the current ISH awards and prizes, and past winners, can be viewed on the ISH website.

The Awards Committee reports to the Executive Committee and is responsible for (1) soliciting nominations for the awards from ISH members; (2) making recommendations and assist with the selection of awards to individuals, groups or institutions honoured by the Society and with the selection of Distinguished and Honorary Members and (3) assessing applications equally on their merits and eligibility.

This committee will be updated soon!

Communications Committee

The Communications Committee has responsibility for the production of the Society newsletter, the monthly e-Bulletin, all Society print and promotional material and the development and maintenance of the website at an editorial level. This Committee must ensure the correct use of the Society logos and provide direction for social media activities and other new methods of communication with members. The Communications Committee reports to, and advises, the Executive Committee on the communications strategy for the Society.

  • Rafael Castillo/Members

    Rafael Castillo Chair, Communications Committee

    Philippines

    more

    As a senior clinical cardiologist at the Manila Doctor’s Hospital and a pioneering faculty member at the Adventist University College of Medicine, I’m part of a group involved in clinical trials evaluating drug and non-drug interventions in the management of high-risk hypertensive patients with various comorbidities. I’m a past president of the Asian Pacific Society of Hypertension, Philippine Heart Association/Philippine College of Cardiology, Philippine Society of Hypertension; and past chair of the Philippine Specialty Board of Adult Cardiology.

  • Dylan Burger/Members

    Dylan Burger Lead, Social Media and YouTube Channel

    Canada

    more

    My research focuses on the cellular mechanisms of oxidative stress, inflammation and vascular dysfunction in hypertension. I have a particular interest in the role of microparticles, tiny cellular fragments shed from stressed cells of the vasculature, in hypertension and vascular disease.

Hypertension News Sub-committee

  • Lars H. Lindholm/Hypertension News

    Lars H. Lindholm Chair

    Sweden

    more

    I have been President of the Swedish Society of Hypertension (1989-92), Secretary (the first) of the European Society of Hypertension, ESH (1989-97) , and President of the ISH (2006-8). Since 2009, I have been an honorary member of the British Society of Hypertension.

    My interest in hypertension and its risks started in the late 1970s and I defended my doctoral thesis on this topic in 1994. Since 1998, I am Professor and chairman at the Department of Public Health and Clinical Medicine at Umeå University, Sweden.

  • Maciej Tomaszewski - Membership Committee

    Maciej Tomaszewski Secretary

    UK

    more

    My research interests focus primarily on genetics and genomics of cardiovascular disorders with a particular emphasis on essential hypertension and its complications.

    I am also interested in genetic and environmental background of sexual dimorphism in cardiovascular risk (why men develop and die of cardiovascular disorders more frequently than age-matched women).

  • Thomas Kahan/Members

    Thomas Kahan Member

    Sweden

    more

    I am professor of medicine at Karolinska Institutet, Stockholm and serve as a senior consultant in cardiology at Danderyd University Hospital, Stockholm, where I am head of the Unit for Cardiovascular Risk Assessment. My main research areas are neurohormonal mechanisms in the control of blood pressure and cardiac function, with a focus on structural myocardial and vascular changes, and neuroendocrine mechanisms in heart failure. Other areas of interest are cardiovascular risk assessment and prevention.

Corporate Liaison Committee

The Corporate Liaison Committee reports to the Executive Committee and is charged with maintaining constructive relations with the corporate sector. Industry supporters can include pharmaceutical companies, device manufacturers and organisations with an interest in hypertension and cardiovascular research. For example, these could include representatives of the food industry or companies producing tele-medical devices (used for remote care and collection of data in remote locations in both developed and less developed countries).

  • Michael Weber/Members

    Michael Weber Chair

    U.S.A.

    more

    I am involved in the contemporary practice of preventative cardiology, with a focus on hypertension. I am currently the editor of the Journal of Clinical Hypertension and so have an excellent opportunity to be aware of new developments and controversies in the field.

    I have a major interest in clinical trials in patients with hypertension or at high cardiovascular risk, and am particularly interested in how current evidence based on this research -- much of which is inconclusive -- can be used to help define hypertension and guide clinical practice.

    I have also been involved in the development of new drugs for treating hypertension and in understanding how they can be used to the greatest clinical advantage in our patients.

  • Masatsugu Horiuchi - Membership Committee

    Masatsugu Horiuchi Secretary

    Japan

    more

    I am carrying out basic and pharmacological research in hypertension as a research-clinician-scientist. My main research interests include the roles of renin-angiotensin system in blood pressure regulation, vascular biology and brain function with particular regard to cognitive function.

  • Sofie Brouwers

    Sofie Brouwers Member

    Switzerland

    more

    As a clinician-scientist, I conduct therapeutic research along with my clinical work. My basic research activities focus on the pathophysiology of hypertension, with special interest for the role of the renin angiotensin system and the central nervous system in the long-term regulation of blood pressure.

  • Cheol-Ho-kim / Members

    Cheol-Ho Kim Member

    Korea

    more

    I am the chief of the Geriatric Centre of Seoul National University Bundang Hospital, working as the Chair of Scientific Affairs for the organizing committee of the ISH 2016 in Seoul, as the Director of Planning for the Korean Society of Hypertension and as a member of the Board of Trustees of the Asian Pacific Society of Hypertension. My main interest is hypertension especially in the elderly and related clinical studies.

  • Sadayoshi Ito

    Sadayoshi Ito Member

    Japan

    more

    My areas of research are the renin-angiotensin-aldosterone system and glomerular hemodynamics in basic research, and hemodynamics in hypertension, secondary hypertension and chronic kidney disease in clinical research.

  • Dorairaj Prabhakaran/Members

    Dorairaj Prabhakaran Member

    India

    more

    I am a cardiologist and epidemiologist and currently the Executive Director of Initiative for Cardiovascular Health in Developing Countries (ICHEALTH) and Director Centre of Excellence, Centre for Cardio-metabolic Risk Reduction in South Asia (strategic grant funded by the National Institutes of Health and United Health group) at the Public Health Foundation of India.

  • Rhian Touyz/Secretary & Forum Officer

    Rhian Touyz Member

    UK

    more

    I am the British Heart Foundation Chair in Cardiovascular Medicine, based in the Institute of Cardiovascular and Medical Sciences at the University of Glasgow.

    I am a clinician-scientist investigating the molecular and cellular mechanisms of hypertension. I am committed to hypertension through clinical and basic research, clinical service, teaching, mentoring and leadership and to establishing international networks for trainees and new investigators in hypertension research.

  • Thomas Unger

    Thomas Unger Member

    Netherlands

    more

    My research interest has been focused on peptidergig systems, in particular the Renin-Angiotensin system (RAS) and its CNS-related and peripheral role in the pathophysiology of cardiovascular diseases. As a basic and clinical pharmacologist, I have performed numerous pre-clinical studies and participated in clinical trials investigating the therapeutic aspects of modulating the RAS in hypertension and related diseases, and I have contributed to the development of several RAS modulating drugs.

  • Praveen Veerabhadrappa - Membership Committee

    Praveen Veerabhadrappa Member

    U.S.A.

    more

    My research is focused on the Blood Pressure-measurement/monitoring (ABPM) and the effects of lifestyle modification on endothelial cell function (FMD/IMT) and vascular inflammatory biomarkers in hypertensive subjects.

  • Ji-Guang Wang - Membership Committee

    Ji-Guang Wang Member

    China

    more

    My research interests in the field of human hypertension include population-based epidemiological studies, randomized clinical trials, structure and function of the vascular system, and pathophysiological studies on the basis of biological markers such as genetic polymorphisms.

ISH International Forum

The International Forum of the ISH embodies and nurtures the global nature of the ISH and was first established in 1992. It is a consultative forum, the mandate of which is to establish effective liaison between the ISH and National and Regional Societies of Hypertension or Councils of High Blood Pressure Research (known as Affiliated Societies). It also provides a unique infrastructure and platform for networking and “cross-talk” between Societies. Presidents of ISH Affiliated Societies, or their representaties, are invited to attend a Society meeting at the time of the ISH Biennial Scientific Meetings. ISH International Forum Officers report to the Executive Committee of the Society.

View a list of ISH Affiliated Societies.

  • Louise Burrell/Chair, ISH International Forum

    Louise Burrell Chair, ISH International Forum

    Australia

    more

    My research interests include the pathophysiology of hypertension, with particular regard to the renin angiotensin system; diabetic heart disease and the role of echocardiography; and novel biomarkers in coronary artery disease.

Membership Committee

The Membership Committee advises the Council on the election of members or fellows from all categories of membership (Professional Member, Emerging Leader, Research Fellow and Emeritus Fellow) and on the exemption from fees for Professional Members from countries with economic hardship.

  • Alta Schutte - Chair, Membership Committee

    Alta Schutte Chair

    South Africa

    more

    As the Research Chair in Chronic Diseases in South Africa, my research spans clinical and epidemiological population studies focusing on the development of hypertension in African communities. By using longitudinal transdisciplinary research programmes I aim to identify novel markers and/or bio-signatures as early predictors of vascular dysfunction in an attempt to contribute to the prevention of hypertension.

  • Claudio Borghi

    Claudio Borghi Member

    Italy

    more

    My main areas of interest are the hypertension and related cardiovascular risk factors and drug therapy of hypertensive disease. In particular I am very interested in the interactions between hypertensive disease and metabolic risk factors paying a special attention to epidemiology, pathophysiology and drug treatment including the options supporting the use of different preventive approaches in patients with complex CV risk profile. I am also involved in the development of a nutraceutical approach to the management of hypertension and related risk factors.

  • Rafael Castillo/Members

    Rafael Castillo Member

    Philippines

    more

    As a senior clinical cardiologist at the Manila Doctor’s Hospital and a pioneering faculty member at the Adventist University College of Medicine, I’m part of a group involved in clinical trials evaluating drug and non-drug interventions in the management of high-risk hypertensive patients with various comorbidities. I’m a past president of the Asian Pacific Society of Hypertension, Philippine Heart Association/Philippine College of Cardiology, Philippine Society of Hypertension; and past chair of the Philippine Specialty Board of Adult Cardiology.

  • Evi Christofidou/Members

    Evi Christofidou Member

    UK

    more

  • Nadia Khan

    Nadia Khan Member

    Canada

    more

    I am a clinician scientist in epidemiology and health services research. My research area is focused on ethnic and sex differences in hypertension and cardiovascular disease chronic disease management.

  • Yoshihiro Kokubo - Scientific Council

    Yoshihiro Kokubo Member

    Japan

    more

    I am a chief doctor in the National Cerebral and Cardiovascular Center, Japan. My specialty is preventive medicine and epidemiology, especially related to hypertension and kidney dysfunction. I contribute to many international societies in variety of capacities and editorial board activities in the areas of hypertension, stroke, and preventive medicine.

  • Dorairaj Prabhakaran - Membership Committee

    Dorairaj Prabhakaran Member

    India

    more

    I am a cardiologist and epidemiologist and currently the Executive Director of Initiative for Cardiovascular Health in Developing Countries (ICHEALTH) and Director Centre of Excellence, Centre for Cardio-metabolic Risk Reduction in South Asia (strategic grant funded by the National Institutes of Health and United Health group) at the Public Health Foundation of India.

  • Agustin Ramirez - Membership Committee

    Agustin Ramirez Member

    Argentina

    more

    Areas related to hypertension: Renal Sodium Handling, Autonomic Nervous System and Blood Pressure Control, metabolic Syndrome and Hypertension.

  • Markus Schlaich - Scientific Council

    Markus Schlaich Member

    Australia

    more

    I am the Dobney Chair in Clinical Research at the University of Western Australia, based at the Royal Perth Hospital. As a clinician-scientist and renal physician I have specific interest in hypertension associated with chronic kidney disease and the role of the sympathetic nervous system in this scenario. My major aim is to translate evidence from mechanistic studies into clinical practice to improve outcomes for patients with hypertension and associated co-morbidities.

  • Maciej Tomaszewski - Membership Committee

    Maciej Tomaszewski Secretary

    UK

    more

    My research interests focus primarily on genetics and genomics of cardiovascular disorders with a particular emphasis on essential hypertension and its complications.

    I am also interested in genetic and environmental background of sexual dimorphism in cardiovascular risk (why men develop and die of cardiovascular disorders more frequently than age-matched women).

  • Thomas Unger

    Thomas Unger Member

    Netherlands

    more

    My research interest has been focused on peptidergig systems, in particular the Renin-Angiotensin system (RAS) and its CNS-related and peripheral role in the pathophysiology of cardiovascular diseases. As a basic and clinical pharmacologist, I have performed numerous pre-clinical studies and participated in clinical trials investigating the therapeutic aspects of modulating the RAS in hypertension and related diseases, and I have contributed to the development of several RAS modulating drugs.

  • Praveen Veerabhadrappa - Membership Committee

    Praveen Veerabhadrappa Member

    U.S.A.

    more

    My research is focused on the Blood Pressure-measurement/monitoring (ABPM) and the effects of lifestyle modification on endothelial cell function (FMD/IMT) and vascular inflammatory biomarkers in hypertensive subjects.

  • Richard Wainford - Membership Committee

    Richard Wainford Member

    USA

    more

    My research interests are focused on understanding the pathophysiology of hypertension, with particular regard to central neural control of the kidney and the implications of this for long-term blood pressure regulation. As such my research is focused on the areas of: Renal Sodium Handling, Neural Control of Blood Pressure, Salt-Sensitive Hypertension.

  • Ji-Guang Wang - Membership Committee

    Ji-Guang Wang Member

    China

    more

    My research interests in the field of human hypertension include population-based epidemiological studies, randomized clinical trials, structure and function of the vascular system, and pathophysiological studies on the basis of biological markers such as genetic polymorphisms.

Mentorship and Training Committee

  • Fadi Charchar/Members

    Fadi Charchar Chair

    Australia

    more

    My research interests focus on genomics of cardiovascular disease in humans and animal models. I have a special interest in the contribution of the Y chromosome and microRNA to hypertension.

  • Vanja Ivkovic/Members

    Vanja Ivkovic Member

    Croatia

    more

  • Yoshihiro Kokubo - Scientific Council

    Yoshihiro Kokubo Member

    Japan

    more

    I am a chief doctor in the National Cerebral and Cardiovascular Center, Japan. My specialty is preventive medicine and epidemiology, especially related to hypertension and kidney dysfunction. I contribute to many international societies in variety of capacities and editorial board activities in the areas of hypertension, stroke, and preventive medicine.

  • Jolanta Malyszko/Members

    Jolanta Malyszko Member

    Poland

    more

    My major interest is hypertension in patients with kidney disease and those on renal replacement therapy (dialysis, transplantation), diabetic kidney disease, cardiovascular complications as well as endothelial dysfunction in nephrology.

  • Francine Marques/Members

    Francine Marques Member

    Australia

    more

    My research focuses on the molecular mechanisms leading to hypertension, in particular those involving microRNAs and the gut microbiota. My aim is to combine models of disease with human studies to facilitate translation of research and decrease the burden of hypertension.

  • Daniel Piskorz/Members

    Daniel Piskorz Member

    Argentina

    more

    I am the Chair in the Cardiovascular Research Center at the Rosario British Sanatorium, based in Rosario city, Argentina. As a cardiologist my main topic of interest is left ventricular hypertrophy and dysfunction. My research is focused on understanding the pathophysiology of hypertensive cardiac damage, diagnosis and the clinical consequences.

  • Richard Wainford - Scientific Council

    Richard Wainford Member

    USA

    more

    My research interests are focused on understanding the pathophysiology of hypertension, with particular regard to central neural control of the kidney and the implications of this for long-term blood pressure regulation. As such my research is focused on the areas of: Renal Sodium Handling, Neural Control of Blood Pressure, Salt-Sensitive Hypertension.

New Investigator Committee

The New Investigator Committee (NIC) is charged with encouraging and supporting initiatives to attract and retain younger members of the ISH and reports to the Executive Committee of the Society.

The ISH New Investigator Network (ISHNIN) serves as a platform for interaction between students and new investigators and allows new avenues for communication, collaboration and education. The network provides opportunities for all new scientists within the ISH to interact and build relationships, as well as to gain experience and exposure within the Society as they start their scientific careers. The network is run by the committee and mains a presence on the ISH website and social media platforms including Facebook, LinkedIn, Twitter and YouTube.

Go to the ISH New Investigator Network.

Click here to view a list of the New Investigator Committee Members

Past Presidents

  • IH Page USA 1966-1970
  • F Gross Germany 1970-1976
  • JIS Robertson UK 1976-1978
  • A Zanchetti Italy 1978-1980
  • JO Davis USA 1980-1982
  • AE Doyle Australia 1982-1984
  • L Hansson Sweden 1984-1986
  • JH Laragh USA 1986-1988
  • G Mancia Italy 1988-1990
  • PA van Zwieten The Netherlands 1990-1992
  • JP Chalmers Australia 1992-1994
  • K Arakawa Japan 1994-1996
  • JN Cohn USA 1996-1998
  • K-H Rahn Germany 1998-2000
  • A Mimran France 2000-2002
  • LJ Beilin Australia 2002-2004
  • MH Alderman USA 2004-2006
  • LH Lindholm Sweden 2006-2008
  • AM Heagerty UK 2008-2010
  • Stephen Harrap Australia 2010-2012
  • Ernesto Schiffrin Canada 2012-2014
  • Rhian Touyz UK 2014-2016

Regional Advisory Groups (RAGs)

The purpose of the Regional Advisory Groups (RAGs) is to provide comprehensive Society representation globally, to distil regional issues and encourage and enhance education and biomedical research in the fields of hypertension and associated cardiovascular dieases.

ISH has created RAGs for (1) Africa (2) Asia and Australasia (3) Central and South America (4) Eastern Europe and Middle East (5) Western Europe and North America. Each RAG reports to the Executive Committee of the Society.

Africa RAG

  • Albertino Damasceno /Member

    Albertino Damasceno Chair

    Mozambique

    Areas of interest:

    • Epidemiology of Hypertension and risk factors
    • Stroke
    • Salt and Hypertension
    • 24 H monitoring of the Blood Pressure

view all members

  • Hind Beheiry /Members

    Hind Beheiry Member

    Sudan

    more

    I am Deputy Dean and the director of the Medical Research Centre Faculty of Medicine, International University of Africa and executive committee member and treasurer of Sudanese Society of Hypertension. My areas of interest are the RAAS, Pre-eclampsia and Genetics in Essential Hypertension in Africa.

  • Anastase Dzudie /Members

    Anastase Dzudie Member

    Cameroon

    more

    I am a cardiologist and scientist with special interest in chronic disease management. My research area is focused on investigating pathways to improving hypertension and other risk factors control in sub Saharan African populations

  • Solomon Kadiri/Members

    Solomon Kadiri Member

    Nigeria

    more

    I am a nephrologist with interest in hypertension. My areas of interest are hypertension and the kidney, especially the effects of hypertension on the kidney, and the epidemiology of hypertension. I have also participated in the writing of guidelines for the management of hypertension.

  • Ruan Kruger/Members

    Ruan Kruger Member

    South Africa

    more

    I am a basic scientist with special interest in clinical and epidemiological population studies focusing on ethnic phenotyping of cardiovascular pathophysiology related to hypertension, arterial stiffness and cardiac impairment (echocardiography). My research particularly includes novel biomarkers and early predictors of cardiovascular disease aiming to contribute to the prevention of early incidence in sub-Saharan Africa.

  • Jean-Rene M'Buyamba-Kabungu/Members

    Jean-René M 'Buyamba-Kabungu Member

    D.R. Congo

    more

  • Dike Ojji/Members

    Dike Ojji Member

    Nigeria

    more

  • Ikechi Okpechi/Members

    Ikechi Okpechi Member

    South Africa

    more

    I am a nephrologist in Cape Town and an educational ambassador for the International Society of Nephrology (ISN) in Africa. My areas of interest in research include glomerulonephritis in Africans and blood pressure treatment and control in black Africans.

  • Basden Onwubere/Members

    Basden Onwubere Member

    Nigeria

    more

    My area of interest in High Blood Pressure is in prevention and control. I am also interested in the effect of uncontrolled high blood pressure on the heart.

  • Brian Rayner/Members

    Brian Rayner Member

    South Africa

    more

    My research interests are therapy of hypertension, mutations in the ENaC, genetic determinants of salt sensitivity, HIVAN, vascular calcification and chronic kidney disease, primary aldosteronism, assessing adherence in hypertensive patients, ethics of rationing dialysis therapy, AKI and genetics of severe hypertension in blacks. I have a major interest in hypertension guidelines, and together with Professor Seedat wrote the 2011 South African Hypertension Guideline.

  • Alta Schutte / New Investigators Liaison Officer

    Alta Schutte New Investigators Liaison Officer

    South Africa

    more

    As the Research Chair in Chronic Diseases in South Africa, my research spans clinical and epidemiological population studies focusing on the development of hypertension in African communities. By using longitudinal transdisciplinary research programmes I aim to identify novel markers and/or bio-signatures as early predictors of vascular dysfunction in an attempt to contribute to the prevention of hypertension.

Asia & Australasia RAG

  • Cheol-Ho-kim / Members

    Cheol-Ho Kim Deputy Chair

    Korea

    I am the chief of the Geriatric Centre of Seoul National University Bundang Hospital, working as the Chair of Scientific Affairs for the organizing committee of the ISH 2016 in Seoul, as the Director of Planning for the Korean Society of Hypertension and as a member of the Board of Trustees of the Asian Pacific Society of Hypertension. My main interest is hypertension especially in the elderly and related clinical studies.

view all members

  • Rafael Castillo/Members

    Rafael Castillo Member

    Philippines

    more

    As a senior clinical cardiologist at the Manila Doctor’s Hospital and a pioneering faculty member at the Adventist University College of Medicine, I’m part of a group involved in clinical trials evaluating drug and non-drug interventions in the management of high-risk hypertensive patients with various comorbidities. I’m a past president of the Asian Pacific Society of Hypertension, Philippine Heart Association/Philippine College of Cardiology, Philippine Society of Hypertension; and past chair of the Philippine Specialty Board of Adult Cardiology.

  • Sadayoshi Ito

    Sadayoshi Ito Member

    Japan

    more

    My areas of research are the renin-angiotensin-aldosterone system and glomerular hemodynamics in basic research, and hemodynamics in hypertension, secondary hypertension and chronic kidney disease in clinical research.

  • Tazeen Jafar /Member

    Tazeen Jafar Member

    Singapore

    more

  • Trefor Morgan/APSH Representative

    Trefor Morgan Member

    Australia

    more

    I am a Physiologist Clinician with experimental, and clinical involvement in Salt and water Metabolism and the renin angiotensin system. Trained as a nephrologist and cardiologist.

    Secretary General of the Asian Pacific Society of Hypertension.

  • Akira Nishiyama

    Akira Nishiyama Member

    Japan

    more

    My research interests in both basic and clinical studies have been focused on the pathophysiology of life-style disease including hypertension, renal disease, diabetes, senescence and cancer with particular regard to the renin-angiotensin-aldosterone system, renal salt and glucose handling, sympathetic nervous system, genome instability, etc.

  • Dorairaj Prabhakaran/Members

    Dorairaj Prabhakaran Member

    India

    more

    I am a cardiologist and epidemiologist and currently the Executive Director of Initiative for Cardiovascular Health in Developing Countries (ICHEALTH) and Director Centre of Excellence, Centre for Cardio-metabolic Risk Reduction in South Asia (strategic grant funded by the National Institutes of Health and United Health group) at the Public Health Foundation of India.

  • Ji-Guang Wang/Members

    Ji-Guang Wang Member

    China

    more

    My research interests in the field of human hypertension include population-based epidemiological studies, randomized clinical trials, structure and function of the vascular system, and pathophysiological studies on the basis of biological markers such as genetic polymorphisms.

Central & South America RAG

  • Agustin Ramirez/Members

    Agustin Ramirez Chair

    Argentina

    Areas related to hypertension: Renal Sodium Handling, Autonomic Nervous System and Blood Pressure Control, metabolic Syndrome and Hypertension.

view all members

  • Eduardo Barbosa/Members

    Eduardo Barbosa Member

    Brazil

    more

    My main areas of interest in relation to blood pressure are use of biomarkers in hypertension (focus in PWV); prevention of stroke in hypertension (Stroke Risk Analyses) ; optimisation of blood pressure measurement ( Home Blood Pressure Monitoring) and therapeutic in hypertension.

  • Carlos Ferrario/Members

    Carlos Ferrario Member

    U.S.A

    more

    My research career spans multiple important contributions dealing with exploring the biochemical and physiological mechanisms regulating the expression of renin angiotensin system components, the characterization of angiotensin-(1-7) as an endogenous antagonist of the actions of angiotensin II, and the demonstration of the regulatory influence of angiotensin II in the expression of angiotensin converting enzyme 2.

  • Fernando Lanas/Members

    Fernando Lanas Member

    Chile

    more

    I am Vice President and President Elect of the Chilean Society of Hypertension. My research interest is cardiovascular risk factors epidemiology, including hypertension, in Chile and Latin America through the conduct of the PURE and CESCAS cohort studies. I am also interested in improving risk factors control in primary and secondary prevention.

  • Rafael Hern‡ndez-Hern‡ndez/Members

    Rafael Hernandez-Hernandez Member

    Venezuela

    more

    Main concerns in hypertension: Clinical Pharmacology of drugs used for the treatment of hypertension; changes in platelet aggregation induced by antihypertensive drugs and variability during circadian rhythm.

    Also study of the epidemiology of hypertension and other cardiovascular risk factors in Latin America countries.

  • Cesar Romero/Members

    Cesar Romero Member

    USA

    more

    I am interested in mechanism of hypertension. As a basic researcher I am interested in renal mechanism of hypertension and as clinician I am interested in resistant hypertension and hypertension in special populations like young patients and HIV infected patients.

  • Ramiro Sanchez/Members

    Ramiro Sanchez Member

    Argentina

    more

    I am a board member of the Latin America Society of Hypertension (LASH) and via this role am involved in educational and guidelines activities in Latin America. My main fields of research are salt sensitivity of hypertension, hypertension in diabetic patients and treatment of hypertension in low and middle income countries.

  • Fernando Wyss/Members

    Fernando Wyss Member

    Guatemala

    more

    My work focuses on cardiovascular epidemiology, hypertension research, cardiovascular prevention and ambulatory blood pressure monitoring. I have also been involved in the research of new drugs for treating hypertension and diabetes.

Eastern Europe & Middle East RAG

  • Naftali Stern/Members

    Peter Nilsson Chair

    Sweden

    My main area of expertise is cardiovascular and metabolic risk mechanisms. This is especially relevant for studies related to the Early Vascular Aging (EVA) syndrome – a cardiovascular risk syndrome based mainly on the combination of increased arterial stiffness (pulse wave velocity), impaired glucose metabolism, telomere length shortening, and early signs of atherosclerosis (intima media thickness in art. carotis). Another field of interest is the gene-environment interactions behind the development of obesity and type 2 diabetes, but also the study of patients with type 1 diabetes of long duration but escaping major complications (PROLONG study).

view all members

  • Mustafa Arici/Members

    Mustafa Arici Member

    Turkey

    more

    My main areas of interest in hypertension are epidemiology of hypertension, salt and blood pressure control, renin-angiotensin system and blood pressure and hypertension and renal protection.

  • Adel Berbari/Members

    Adel Berbari Member

    Lebanon

    more

    1- Relation between renal function and hypertension

    2- Evaluation and effects of arterial stiffness on renal function

    3- Cardiorenal association The effect of the blockade of the renin-angiotensin-aldosterone system in particular

  • Michael Bursztyn/Members

    Michael Bursztyn Member

    Israel

    more

    I am a clinician and researcher interested in the broad spectrum of hypertension, with special focus on blood pressure measurement, derivation of physiologic variables from ambulatory blood pressure measurements, hypertension in the elderly and that associated with pregnancy.

  • Hermann Haller/Members

    Hermann Haller Member

    Germany

    more

    Main interests in clinical research:

    • diagnostics and treatment of renovascular hypertension
    • hypertension and the vasculature in diabetes
    • hypertension in organ transplantation
    • novel therapeutic devices such as carotid sinus stimulation and renal sympathetic nerve ablation Main interests in basic science
    • the biology of the vascular wall and endothelial function
    • endothelial cell permeability
    • cell adhesion and inflammation
    • stem cell precursors of the endothelium
  • Fady Hannah-Shmouni/Members

    Fady Hannah-Shmouni Member

    USA

    more

    I am a clinical fellow in endocrinology and genetics at the National Institutes of Health, USA. My research interests are in adrenal and pituitary disorders due to genetic defects and late-onset inborn errors of metabolism. I joined the ISH New Investigator Committee in 2012 and currently lead the ISH Spotlight initiative.

  • Bojan Jelakovic/Members

    Bojan Jelakovic Member

    Croatia

    more

  • Jacek Jóźwiak /Members

    Jacek Jóźwiak Member

    Poland

    more

    My specialty is preventive medicine and epidemiology in primary care, especially related to risk factors of cardiovascular diseases: arterial hypertension, dyslipidemia (familial hipercholesterolemia), obesity, diabetes mellitus and smoking. As a clinician-scientist I have a specific interest in cardiometabolic and cardiovascular diseases associated with metabolic syndrome. My research interests include epidemiology of arterial hypertension, atherosclerosis, coronary heart disease, myocardial infarction and stroke also. I have extensive experience in the execution of national epidemiological and multicenter studies in the area of civilization diseases and public health.

  • Alexandra Konradi/Members

    Alexandra Konradi Member

    Russsia

    more

    I am chief of the Hypertension Department of the Almazov Research Medical Center in St.Petersburg, an ESH centre of excellence. My main areas of interest are resistant hypertension and renovascular hypertension, epidemiology, genetics and epigenetic of hypertension. I work a lot in autonomic regulation and ABPM in hypertension, I am also leading the sleep laboratory and OSA in hypertension and metabolic syndrome. I was the President of the Russian Antihypertensive League 2009-2011, have been an ESC Fellow since 2014 and an ISH and ESH member since 2000.

  • Dragan Lovic/Members

    Dragan Lovic Member

    Serbia

    more

    Areas of interest in a field of Hypertension: Obesity , ABPM , pathophisiology of Hypertension and arrithmias.

  • Jolanta Malyszko/Members

    Jolanta Malyszko Member

    Poland

    more

    My major interest is hypertension in patients with kidney disease and those on renal replacement therapy (dialysis, transplantation), diabetic kidney disease, cardiovascular complications as well as endothelial dysfunction in nephrology.

  • Ivan Starostin/Members

    Ivan Starostin Member

    Russia

    more

  • Yuriy Sirenko/Members

    Yuriy Sirenko Member

    Ukraine

    more

    My main areas of interest are secondary hypertensions, resistant hypertension, arterial wall properties in patients with hypertension and cardiovascular risk and central blood pressure evaluation. I am a head of arterial hypertension department in National Institute of Cardiology and also I am a Head of Ukrainian Antihypertensive Society.

  • Davyd Yakontov/Members

    Davyd Yakontov Member

    Russia

    more

    I am professor of cardiology of Novosibirsk Medical University and senior clinical therapeutist of Novosibirsk Clinical Cardiological Centre. My main areas of interest are hypertension prevalence in Siberia, hypertension and concomitant diseases, hypertension in young adults, early vascular aging syndrome, resistant hypertension and hypertension pharmacotherapy.

Western Europe & North America RAG

  • Michael Weber/Chair

    Michael Weber Chair

    U.S.A.

    I am involved in the contemporary practice of preventative cardiology, with a focus on hypertension. I am currently the editor of the Journal of Clinical Hypertension and so have an excellent opportunity to be aware of new developments and controversies in the field.

    I have a major interest in clinical trials in patients with hypertension or at high cardiovascular risk, and am particularly interested in how current evidence based on this research -- much of which is inconclusive -- can be used to help define hypertension and guide clinical practice.

    I have also been involved in the development of new drugs for treating hypertension and in understanding how they can be used to the greatest clinical advantage in our patients.

view all members

  • Dylan Burger/Members

    Dylan Burger Member

    Canada

    more

    My research focuses on the cellular mechanisms of oxidative stress, inflammation and vascular dysfunction in hypertension. I have a particular interest in the role of microparticles, tiny cellular fragments shed from stressed cells of the vasculature, in hypertension and vascular disease.

  • Evi Christofidou/Members

    Evi Christofidou Member

    UK

    more

  • Nadia Khan

    Nadia Khan Member

    Canada

    more

    I am a clinician scientist in epidemiology and health services research. My research area is focused on ethnic and sex differences in hypertension and cardiovascular disease chronic disease management.

  • Roland Schmieder/Members

    Roland Schmieder Member

    Germany

    more

    I have extensive experience in the execution of clinical observational and international multicenter studies.

    My research interests include nephrology, hypertension, non-invasive cardiology and vascular medicine, with a focus on hypertensive damage to the heart, kidneys, arteries and retinal circulation and its treatment.

  • Richard Wainford - Scientific Council

    Richard Wainford Member

    USA

    more

    My research interests are focused on understanding the pathophysiology of hypertension, with particular regard to central neural control of the kidney and the implications of this for long-term blood pressure regulation. As such my research is focused on the areas of: Renal Sodium Handling, Neural Control of Blood Pressure, Salt-Sensitive Hypertension.

Research, Science and Education Committee

  • Neil Poulter/Members

    Neil Poulter President / Chair

    UK

    more

    My main areas of interest in relation to blood pressure are investigating evaluating the optimisation of blood pressure measurement and control and to ensure maximal prevention of cardiovascular diseases in hypertensive patients from all the major ethnic groups.

  • Claudio Borghi

    Claudio Borghi Member

    Italy

    more

    My main areas of interest are the hypertension and related cardiovascular risk factors and drug therapy of hypertensive disease. In particular I am very interested in the interactions between hypertensive disease and metabolic risk factors paying a special attention to epidemiology, pathophysiology and drug treatment including the options supporting the use of different preventive approaches in patients with complex CV risk profile. I am also involved in the development of a nutraceutical approach to the management of hypertension and related risk factors.

  • Fadi Charchar/Members

    Fadi Charchar Member

    Australia

    more

    My research interests focus on genomics of cardiovascular disease in humans and animal models. I have a special interest in the contribution of the Y chromosome and microRNA to hypertension.

  • Alta Schutte / New Investigators Liaison Officer

    Alta Schutte Vice President / Member

    South Africa

    more

    As the Research Chair in Chronic Diseases in South Africa, my research spans clinical and epidemiological population studies focusing on the development of hypertension in African communities. By using longitudinal transdisciplinary research programmes I aim to identify novel markers and/or bio-signatures as early predictors of vascular dysfunction in an attempt to contribute to the prevention of hypertension.

  • Maciej Tomaszewski - Scientific Council

    Maciej Tomaszewski Secretary / Member

    UK

    more

    My research interests focus primarily on genetics and genomics of cardiovascular disorders with a particular emphasis on essential hypertension and its complications. I am also interested in genetic and environmental background of sexual dimorphism in cardiovascular risk (why men develop and die of cardiovascular disorders more frequently than age-matched women).

  • Thomas Unger

    Thomas Unger Member

    Netherlands

    more

    My research interest has been focused on peptidergig systems, in particular the Renin-Angiotensin system (RAS) and its CNS-related and peripheral role in the pathophysiology of cardiovascular diseases. As a basic and clinical pharmacologist, I have performed numerous pre-clinical studies and participated in clinical trials investigating the therapeutic aspects of modulating the RAS in hypertension and related diseases, and I have contributed to the development of several RAS modulating drugs.

  • Ji-Guang Wang/Members

    Ji-Guang Wang Member

    China

    more

    My research interests in the field of human hypertension include population-based epidemiological studies, randomized clinical trials, structure and function of the vascular system, and pathophysiological studies on the basis of biological markers such as genetic polymorphisms.

Women in Hypertension Research Committee

  • Rhian Touyz/Secretary & Forum Officer

    Rhian Touyz Chair

    UK

    more

    I am the British Heart Foundation Chair in Cardiovascular Medicine, based in the Institute of Cardiovascular and Medical Sciences at the University of Glasgow.

    I am a clinician-scientist investigating the molecular and cellular mechanisms of hypertension. I am committed to hypertension through clinical and basic research, clinical service, teaching, mentoring and leadership and to establishing international networks for trainees and new investigators in hypertension research.

  • Sofie Brouwers

    Sofie Brouwers Member

    Switzerland

    more

    As a clinician-scientist, I conduct therapeutic research along with my clinical work. My basic research activities focus on the pathophysiology of hypertension, with special interest for the role of the renin angiotensin system and the central nervous system in the long-term regulation of blood pressure.

  • Louise Burrell - Awards Committee

    Louise Burrell Member

    Australia

    more

    My research interests include the pathophysiology of hypertension, with particular regard to the renin angiotensin system; diabetic heart disease and the role of echocardiography; and novel biomarkers in coronary artery disease.

  • Fadi Charchar/Members

    Fadi Charchar Member

    Australia

    more

    My research interests focus on genomics of cardiovascular disease in humans and animal models. I have a special interest in the contribution of the Y chromosome and microRNA to hypertension.

  • Alta Schutte / New Investigators Liaison Officer

    Alta Schutte Member

    South Africa

    more

    As the Research Chair in Chronic Diseases in South Africa, my research spans clinical and epidemiological population studies focusing on the development of hypertension in African communities. By using longitudinal transdisciplinary research programmes I aim to identify novel markers and/or bio-signatures as early predictors of vascular dysfunction in an attempt to contribute to the prevention of hypertension.

  • Ulrike Steckelings - Women in hypertension Research Committee

    Ulrike Steckelings Member

    Denmark

    more

    My research interests lie in the protective arm of the renin angiotensin system, in particular the angiotensin AT2-receptor and the receptor MAS, spanning from the basic biology of these receptors over pre-clinical studies to test their therapeutic efficacy in cardiovascular (e.g. heart failure, hypertensive and diabetic end organ damage, stroke) and other diseases to the involvement in the development of AT2-recepor agonists for future clinical use.

Join ISH in 3 simple steps...Apply Now

Latest tweets from ISH

The ISH is positively committed to opposing discrimination against people on the grounds of gender, race, colour, nationality, religion, marital status, sexual orientation, class, age, disability, having dependants, HIV status or perceived lifestyle.